SCHEDULE OF TRANSACTIONS WITH OTHER RELATED PARTIES (Details) - USD ($) |
12 Months Ended | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2025 |
Mar. 31, 2024 |
Mar. 31, 2023 |
Jan. 21, 2025 |
Dec. 20, 2024 |
Sep. 30, 2024 |
|||||||||||||||||
IfrsStatementLineItems [Line Items] | ||||||||||||||||||||||
Subscription fee income | [1] | $ 42,680 | $ 71,333 | $ 387,751 | ||||||||||||||||||
Consultancy fee | [2] | 260,417 | 250,000 | 250,000 | ||||||||||||||||||
Write-off of due from related company | [3] | 81,347 | ||||||||||||||||||||
Share-based payments expenses on anti-dilution issuance of Preferred Shares | [4],[5] | 369,648 | ||||||||||||||||||||
Loan from a related company | [6] | 24,548 | 80,219 | 60,712 | ||||||||||||||||||
Loans from immediate holding company | [7] | 129,423 | 187,584 | 78,926 | ||||||||||||||||||
Convertible loan notes | [8] | $ 238,960 | $ 266,520 | $ 80,822 | ||||||||||||||||||
[custom:CapitalizedLoan-0] | $ 3,000,000 | $ 3,500,000 | ||||||||||||||||||||
Number of shares issued | 731,707 | 2,347,134 | ||||||||||||||||||||
Ordinary shares [member] | ||||||||||||||||||||||
IfrsStatementLineItems [Line Items] | ||||||||||||||||||||||
Number of shares issued | 731,707 | |||||||||||||||||||||
|